West Pharmaceutical Services, Inc.

NYSE:WST

Medical - Instruments & Supplies

Healthcare
$404.02 +1.56%

+$5.04 today

Market cap
$28.14B
Beta
1.18
P/E (TTM)
43.6
EPS (TTM)
$7.54
Dividend yield
0.26%
52W Low $206.80High $336.82

Volume 0.59M

Average 0.85M

WST Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

West Pharmaceutical Services, Inc.NYSE: WST

Common Stock · Q2 FY2026 · quarter ended Jun 2026

Common stock broadly unchanged from a year ago

Common stock stood at $18.8M at the end of Q2 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +0.0% a year.

Context

  • Common stock amounted to 0.5% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Common stock increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$18.8M+0.0% QoQ
Last fiscal yearDec 2025
$18.8M+0.0% YoY
Year agoJun 2025
$18.8M+0.0% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year+0.0%——
3-year CAGR+0.0%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
18.8M USD
Year-over-year change
+0.0%
4-year CAGR
+0.0%

Common Stock vs competitors

How WST compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +0.0% is the 4th highest of 5, against a peer median of +1.4%.
  • Common stock amounts to 0.5% of total assets for WST, versus a peer median of 0.0%.
WST Competitors
Common Stock for WST and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
STVNStevanato Group S.p.A.Jun 2026€22.23M EUR+0.0%+0.8%0.8%
WSTWest Pharmaceutical Services, Inc.Jun 2026$18.8M USD+0.0%+0.0%0.5%
ICUIICU Medical, Inc.Jun 2026$2.52M USD+2.0%+1.0%0.1%
ATRAptarGroup, Inc.Jun 2026$732K USD+0.7%+0.9%0.0%
BLFSBioLife Solutions, Inc.Mar 2026$49K USD+2.1%+3.7%0.0%
Peer median (excluding WST) —+1.4%+0.9%0.0%

Competitors are the stored peer set for WST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents762.6M894.3M853.9M484.6M791.3M
Short-term Investments00000
Net Receivables489M507.4M512M552.5M574.4M
Inventory378.4M414.8M434.7M377M443.9M
Other Current Assets112M103M135.8M124M168.6M
Total Current Assets1.74B1.92B1.94B1.54B1.98B
Property, Plant & Equipment (Net)1.13B1.26B1.51B1.69B1.84B
Goodwill109.9M107.3M108.5M106.1M110M
Intangible Assets23M18.4M15.1M10.8M7.7M
Long-term Investments207.7M204.9M210M202.1M212.3M
Tax Assets48.5M65.6M25.7M26M38.4M
Other Non-current Assets55.9M38.4M21.3M74.3M80.1M
Total Non-current Assets1.57B1.7B1.89B2.11B2.29B
Total Assets3.31B3.62B3.83B3.64B4.27B
Account Payables232.2M215.4M242.4M239.3M253.7M
Short-term Debt44.2M2.2M134M18.8M22.7M
Tax Payables39.3M38.5M31M50.3M0
Deferred Revenue48.7M57.3M41.7M49.6M0
Other Current Liabilities45.1M54M54.2M100.5M214.5M
Total Current Liabilities594.1M519M671.8M550.4M654.9M
Long-term Debt208.8M206.7M72.8M202.6M298.4M
Deferred Tax Liabilities4.9M14.3M12.7M20.5M23M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities107.6M98.9M106.7M103.7M22.1M
Total Non-current Liabilities384.3M412.9M276.7M410.7M439.1M
Total Liabilities978.4M931.9M948.5M961.1M1.09B
Common Stock18.8M18.8M18.8M18.8M18.8M
Retained Earnings2.46B2.99B3.52B3.96B4.37B
Accumulated OCI(159.6M)(183M)(143.8M)(258.1M)(105.5M)
Other Stockholders Equity0000(1)
Minority Interest00000
Total Equity2.34B2.68B2.88B2.68B3.18B
Total Debt325.3M317.9M309M305.3M416.7M
Net Debt(437.3M)(576.4M)(544.9M)(179.3M)(374.6M)

West Pharmaceutical Services, Inc.

NYSE:WST

Intrinsic Alpha fair value

Locked

Current Price

$404.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.